Xp11.2 duplication

Last updated
Region of Xp11.2 duplications. Xp11.2.jpg
Region of Xp11.2 duplications.

Xp11.2 duplication is a genomic variation marked by the duplication of an X chromosome region on the short arm p at position 11.2, defined by standard karyotyping (G-banding). This gene-rich, rearrangement prone region can be further divided into three loci - Xp11.21, Xp11.22 and Xp11.23. The duplication could involve any combination of these three loci. While the length of the duplication can vary from 0.5Mb to 55 Mb, most duplications measure about 4.5Mb and typically occur in the region of 11.22-11.23. [1] Most affected females show preferential activation of the duplicated X chromosome. [2] Features of affected individuals vary significantly, even among members of the same family. The Xp11.2 duplication can be 'silent' - presenting no obvious symptoms in carriers - which is known from the asymptomatic parents of affected children carrying the duplication. [3] [4] The common symptoms include intellectual disabilities, speech delay and learning difficulties, while in rare cases, children have seizures and a recognizable brain wave pattern when assessed by EEG (electroencephalography).

Contents

Symptoms and signs

Information on the clinical symptoms and features is taken from the Human Phenotype Ontology database [5] and the Unique database. [1] All affected individuals needn't show all the symptoms. Some of the most noted features are:

Intellectual and Learning Disabilities

Among people who need support with their learning, at least 3% are believed to carry the duplication. [3] It is noted that affected members of the same family with the same Xp11.2 microduplication generally have similar learning profiles. Children with small duplications of 0.5-1.3 Mb seem to have a mild learning difficulty, while others with the typical duplication of around 4.5 Mb generally have a borderline, mild or moderate learning disability. An extreme case with a very large duplication of 55 Mb has shown to have a severe intellectual disability. [3] [6]

Speech Delay

Speech is very commonly affected and usually the first sign. Both speech and comprehension seem to be affected, to various degrees of extent. Low facial muscle tone underlies difficulty in making certain sounds of speech. Nasal or hoarse voice are also observed. Babies are known to be unable to suck from breast in their infancy due to weak facial muscles.

Early Puberty

Early puberty occurs in 80% of the affected children or adults, with girls starting their menstrual cycles as early as age 9 and boys showing signs of puberty at age 8.5. One boy from Unique had completed puberty by age 13. [1]

Weight problems

Affected children show tendency to be overweight. This might indicate metabolism issues.

Lower-extremity Anomalies

Anomalies of lower limbs or feet are common in people with an Xp11.2 duplication, affecting about 71% cases. Features include flat feet, arched feet (pes cavus), clubfoot (talipes), narrow feet, webbed or joined toes/fingers (syndactyly), 5th finger clinodactyly, 5th toe hypoplasia, and tapering fingers. [3] [7]

Unusual EEG Pattern

A typical pattern of electrical activity in the brain of affected children, described as ‘subclinical seizures’ has been noted. A peculiar electroencephalographic pattern characterized by rolandic-like spikes and/or continuous spike wave during slow sleep (CSWS), also called centro-temporal focal spike, exists in childhood. [3]

Minor Facial Features

The common unusual features include a short or flat groove between the nose and upper lip (philtrum), a large, high or deep nasal bridge, bushy eyebrows and/or uni-brow (synophrys), and thin lips. [1] [3] [5]

Cause

Using array-based Comparative Genomic Hybridization (aCGH) to screen 2,400 individuals with isolated or syndromic mental retardation for copy number variation, Giorda et al. (2009) identified 8 (0.33%) unrelated individuals, 2 males and 6 females, with a microduplication at chromosome Xp11.23-p11.22. The rearrangement was familial in 3 patients. A female patient shared a 4.5-Mb duplication with her affected mother and sister, and an unrelated male patient shared a 4.5-Mb duplication with his affected mother and sister. A third unrelated male inherited a smaller 0.8-Mb duplication from his unaffected mother. Three additional individuals had de novo 4.5-Mb duplications, and 2 more had partially overlapping de novo 6.0- and 9.2-Mb duplications. Paternal origin of the duplication was demonstrated in all de novo female cases. Six affected females had selective inactivation of the normal X chromosome, whereas 3 had random X inactivation. Breakpoints could be identified in 8 individuals. The recurrent duplication was flanked distally by a segmental duplication (D-REP at 47.8-48.2 Mb) containing a cluster of genes and pseudogenes of the synovial sarcoma X breakpoint (SSX) and proximally by a complex repeat (P-REP at 52.1-53.1 Mb) rich in SSX, melanoma antigen and X antigen (XAGE) genes. Sequence analysis of the junctions demonstrated that the recurrent 4.5-Mb duplications were mediated by non-allelic homologous recombination (NAHR) or Alu-mediated recombination. The majority of these recombinations occurred between flanking complex segmental duplications. [3] Region of duplication and copy number variation can be further confirmed by Fluorescence In-Situ Hybridization (FISH) and PCR.

Genetics

The duplication at Xp11.2, especially the Xp11.22-11.23 region is syndromic and is implicated in X-linked mental retardation. [8] [4] The chromosomal duplication can be de novo or familial. Familial carriers of small duplication (<1 Mb) show X-linked recessive inheritance. All other affected individuals with larger duplication present dominant expression and comparable clinical phenotypes irrespective of sex, duplication size, and X-inactivation pattern. [3]

Xp11.22 comprises approximately 5 Mb of DNA (chrX:49,800,001–54,800,000, hg19). A number of pathogenic deletions and duplications involving Xp11.22 have been described in individuals with developmental delay, intellectual disability and/or autism. [9] These phenotypes have been attributed to changes in the copy number of several genes including HUWE1 , KDM5C, IQSEC2, TSPYL2, SHROOM4, PHF8 and FAM120C. [10] [11]

HUWE1

The HECT, UBA and WWE domain-containing protein 1 ( HUWE1 ) is a HECT family ubiquitin ligase located on the X chromosome at Xp11.22 with growing genetic links to cancer [12] and intellectual disability. [13] Expression of the HUWE1 gene is found in several mouse tissues including cortex, hippocampus, tongue, eye, kidney, liver, adrenal gland, and fibroblasts. [14] Increased copies of HUWE1 are associated with non-syndromic intellectual disability. [14] [15] Missense mutations in HUWE1 occur in multiple families with intellectual disability, including families with Juberg-Marsidi-Brooks syndrome. [15] [13] [16] Patients with missense mutations in HUWE1 share clinical features with patients with a duplication of HUWE1. This suggests both increased and decreased HUWE1 function could be associated with intellectual disability, but evidence from an in vivo model system supporting or refuting this possibility remains absent.

KDM5C

KDM5C (Lysine-Specific Demethylase 5C) also known as jumonji, A/T-rich interactive domain 1C (JARID1C) is located on the X chromosome at Xp11.22-p11.21. The gene encodes a 1560 amino-acid protein that belongs to the JARID1 subfamily of Arid DNA-binding proteins. [17] The protein possesses H3K4me3-specific demethylase activity and is shown to function as a transcriptional repressor through the RE-1-silencing transcription factor (REST) complex. [18]

The mutations in KDM5C cause Claes-Jensen type [19] [20] syndromic X-linked Intellectual Disability characterized by moderate-to-severe ID, speech abnormalities and other clinical findings such as seizures and aggressive behavior in some individuals. [11] [21] There is also a report of a mutation in a patient with autism spectrum disorder. [22] A study showed that Kdm5c-knockout mice exhibit adaptive and cognitive abnormalities similar to those in human X-linked intellectual disability and concluded that histone methylation dynamics sculpt the neuronal network. [23]

IQSEC2

IQ motif and Sec7 domain 2 (IQSEC2), also known as BRAG1 or IQ-ARFGEF, is located on the X chromosome at Xp11.22 and encodes guanine nucleotide exchange factor for the ARF family of GTP-binding proteins (ARFGEF). [24] It is expressed in the neurons and is involved in cytoskeletal organization, dendritic spine morphology, and excitatory synaptic organization. [25]

Mutations in IQSEC2 are widely associated in cases of X-linked non-syndromic mental retardation, with some carrier females reported with learning disabilities. [26] This gene is known to play a significant role in the maintenance of homeostasis within the neural environment of the human brain. A change of guanine nucleotide exchange factor activity may influence the regulation of actin cytoskeleton organization and neuronal development in the brain by reduced activation of the ARF6 substrate or a defect in the GTP-binding activity. [26]

Two intragenic duplications predicted to cause termination mutations on the X-chromosome involving IQSEC2 were identified in two de novo cases, and one nonsense mutation was described in three additional male patients presenting severe intellectual disability and additional clinical features including neonatal hypotonia, delayed motor skills, seizures, strabismus, autistic-like behavior, stereotypic midline hand movements, microcephaly, little-to-no walking, little-to-no language skills, significant behavioral issues, and mildly abnormal facial features. [27] A novel de novo mutation in the IQSEC2 gene identified through diagnostic exome sequencing showed significant developmental delay, seizures, hypotonia, vision impairments, plagiocephaly, autistic-like features, absent language skills, and abnormal MRI findings. [28] IQSEC2 gene plays a larger role in the cause of X-linked cognitive impairment than previously thought. Additional consideration is warranted with regards to the syndromic nature of its phenotypic association.

TSPYL2

Testis-Specific Protein Y-encoded (TSPY) Like 2 (TSPYL2) codes for a member of the TSPY-like/SET/nucleosome assembly protein-1 superfamily and is located on the X chromosome at Xp11.22. The encoded protein is localized to the nucleolus where it functions in chromatin remodeling and as an inhibitor of cell-cycle progression. [29] Consistent with a possible role for Tspyl2 pathways in neurodevelopment, Xp11.2 microduplication incorporating the TSPYL2 locus has been reported in male patients with Attention Deficit Hyperactivity Disorder. [11]

SHROOM4

Shroom Family Member 4 (SHROOM4), also known as KIAA1202, encodes a member of the APX/Shroom family, which contains an N-terminal PDZ domain and a C-terminal ASD2 motif. It is located on the X chromosome at Xp11.22 and is mainly associated with the Stocco dos Santos X-linked mental retardation syndrome characterized by cognitive disabilities. [30] The encoded protein may play a role in cytoskeletal architecture. Symptoms of SHROOM4 gene mutations in the original family described by Stocco dos Santos include severe intellectual disability, bilateral congenital hip luxation and short stature. The SHROOM4 gene was also found to be disrupted in two unrelated females with mild to moderate intellectual disabilities. Other features included delayed or no speech, seizures, kyphosis and hyperactivity. Carrier females displayed seizures and depression. No mutations in SHROOM4 were identified in more than 1000 control X chromosomes. [30] [31]

See also

X-linked Intellectual Disability

Related Research Articles

<span class="mw-page-title-main">Fragile X syndrome</span> X-linked dominant genetic disorder

Fragile X syndrome (FXS) is a genetic disorder characterized by mild-to-moderate intellectual disability. The average IQ in males with FXS is under 55, while about two thirds of affected females are intellectually disabled. Physical features may include a long and narrow face, large ears, flexible fingers, and large testicles. About a third of those affected have features of autism such as problems with social interactions and delayed speech. Hyperactivity is common, and seizures occur in about 10%. Males are usually more affected than females.

<span class="mw-page-title-main">22q13 deletion syndrome</span> Rare genetic syndrome

22q13 deletion syndrome, also known as Phelan–McDermid syndrome (PMS), is a genetic disorder caused by deletions or rearrangements on the q terminal end of chromosome 22. Any abnormal genetic variation in the q13 region that presents with significant manifestations (phenotype) typical of a terminal deletion may be diagnosed as 22q13 deletion syndrome. There is disagreement among researchers as to the exact definition of 22q13 deletion syndrome. The Developmental Synaptopathies Consortium defines PMS as being caused by SHANK3 mutations, a definition that appears to exclude terminal deletions. The requirement to include SHANK3 in the definition is supported by many but not by those who first described 22q13 deletion syndrome.

<span class="mw-page-title-main">PQBP1</span> Protein-coding gene in the species Homo sapiens

Polyglutamine-binding protein 1 (PQBP1) is a protein that in humans is encoded by the PQBP1 gene.

<span class="mw-page-title-main">SOX3</span> Protein-coding gene in the species Homo sapiens

Transcription factor SOX-3 is a protein that in humans is encoded by the SOX3 gene. This gene encodes a member of the SOX family of transcription factors involved in the regulation of embryonic brain development and in determination of cell fate. The encoded protein acts as a transcriptional activator.

<span class="mw-page-title-main">STAG2</span> Protein-coding gene in humans

Cohesin subunit SA-2 (SA2) is a protein that in humans is encoded by the STAG2 gene. SA2 is a subunit of the Cohesin complex which mediates sister chromatid cohesion, homologous recombination and DNA looping. In somatic cells cohesin is formed of SMC3, SMC1, RAD21 and either SA1 or SA2 whereas in meiosis, cohesin is formed of SMC3, SMC1B, REC8 and SA3.

<span class="mw-page-title-main">OPHN1</span> Protein-coding gene in the species Homo sapiens

Oligophrenin-1 is a protein that in humans is encoded by the OPHN1 gene.

<span class="mw-page-title-main">KDM5C</span> Protein-coding gene in the species Homo sapiens

Lysine-specific demethylase 5C is an enzyme that in humans is encoded by the KDM5C gene. KDM5C belongs to the alpha-ketoglutarate-dependent hydroxylase superfamily.

<span class="mw-page-title-main">PHF8</span> Protein-coding gene in the species Homo sapiens

PHD finger protein 8 is a protein that in humans is encoded by the PHF8 gene.

X-linked intellectual disability refers to medical disorders associated with X-linked recessive inheritance that result in intellectual disability.

<span class="mw-page-title-main">Pitt–Hopkins syndrome</span> Medical condition

Pitt–Hopkins syndrome (PTHS) is a rare genetic disorder characterized by developmental delay, epilepsy, distinctive facial features, and possible intermittent hyperventilation followed by apnea. Pitt-Hopkins syndrome can be marked by intellectual disabilities as well as problems with socializing. It is part of the clinical spectrum of Rett-like syndromes.

DECIPHER is a web-based resource and database of genomic variation data from analysis of patient DNA. It documents submicroscopic chromosome abnormalities and pathogenic sequence variants, from over 25000 patients and maps them to the human genome using Ensembl or UCSC Genome Browser. In addition it catalogues the clinical characteristics from each patient and maintains a database of microdeletion/duplication syndromes, together with links to relevant scientific reports and support groups.

22q11.2 duplication syndrome is a rare genetic disorder caused by a duplication of a segment at the end of chromosome 22.

Epilepsy-intellectual disability in females also known as PCDH19 gene-related epilepsy or epileptic encephalopathy, early infantile, 9 (EIEE9), is a rare type of epilepsy that affects predominately females and is characterized by clusters of brief seizures, which start in infancy or early childhood, and is occasionally accompanied by varying degrees of cognitive impairment. The striking pattern of onset seizures at a young age, genetic testing and laboratory results, potential developmental delays or developmental regression and associated disorders, eases diagnosis.

<span class="mw-page-title-main">Mental retardation and microcephaly with pontine and cerebellar hypoplasia</span> Rare X-linked dominant genetic disorder

Mental retardation and microcephaly with pontine and cerebellar hypoplasia (MICPCH) – also known as mental retardation, X-linked, syndromic, Najm type (MRXSNA); X-linked intellectual deficit, Najm type; intellectual developmental disorder, X-linked, syndromic, Najm type; X-linked intellectual disability–microcephaly–pontocerebellar hypoplasia syndrome; and by variations of these terms – is a rare X-linked dominant genetic disorder of infants characterised by intellectual disability and pontocerebellar hypoplasia. It usually affects females; many males die before birth or not long after.

<span class="mw-page-title-main">MECP2 duplication syndrome</span> Medical condition

MECP2 duplication syndrome (M2DS) is a rare disease that is characterized by severe intellectual disability and impaired motor function. It is an X-linked genetic disorder caused by the overexpression of MeCP2 protein.

<span class="mw-page-title-main">Wieacker syndrome</span> Medical condition

First being described and identified in 1985, Wieacker-Wolff syndrome is a rare, slowly progressive, genetic disorder present at birth and characterized by deformities of the joints of the feet, muscle degeneration, mild intellectual disability and an impaired ability to move certain muscles of the eyes, face and tongue. Wieacker syndrome is inherited as an X-linked recessive trait.

<span class="mw-page-title-main">17q12 microdeletion syndrome</span> Rare genetic anomaly in humans

17q12 microdeletion syndrome, also known as 17q12 deletion syndrome, is a rare chromosomal anomaly caused by the deletion of a small amount of material from a region in the long arm of chromosome 17. It is typified by deletion of the HNF1B gene, resulting in kidney abnormalities and renal cysts and diabetes syndrome. It also has neurocognitive effects, and has been implicated as a genetic factor for autism and schizophrenia.

<span class="mw-page-title-main">Familial opposable triphalangeal thumbs duplication</span> Medical condition

Familial opposable triphalangeal thumb duplication is a limb malformation syndrome and a type of pre-axial polydactyly, characterized by having duplicated opposable triphalangeal thumbs. This condition can be a symptom of other genetic disorders, such as Holt–Oram syndrome and Fanconi anemia. This trait is autosomal dominant and often runs in families. Sometimes big toe duplication, post-axial polydactyly, and syndactyly of the hand and feet can occur alongside this malformation Approximately 20 families with the condition have been described in medical literature.

<span class="mw-page-title-main">HNRNPH2-related disorders</span> Medical condition

HNRNPH2-related disorder is considered as a neurodevelopmental disorder (NDD) caused by heterozygous mutation in the HNRNPH2 gene on the chromosome Xq22.

References

  1. 1 2 3 4 "Unique The Rare Chromosome Disorder Support Group". www.rarechromo.org. Retrieved 2018-02-28.
  2. ↑ "Microduplication Xp11.22-p11.23 syndrome | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved 2018-02-28.
  3. 1 2 3 4 5 6 7 8 Giorda R, Bonaglia MC, Beri S, Fichera M, Novara F, Magini P, et al. (September 2009). "Complex segmental duplications mediate a recurrent dup(X)(p11.22-p11.23) associated with mental retardation, speech delay, and EEG anomalies in males and females". American Journal of Human Genetics. 85 (3): 394–400. doi:10.1016/j.ajhg.2009.08.001. PMC   2771536 . PMID   19716111.
  4. 1 2 Honda S, Hayashi S, Imoto I, Toyama J, Okazawa H, Nakagawa E, Goto Y, Inazawa J (September 2010). "Copy-number variations on the X chromosome in Japanese patients with mental retardation detected by array-based comparative genomic hybridization analysis". Journal of Human Genetics. 55 (9): 590–9. doi: 10.1038/jhg.2010.74 . PMID   20613765.
  5. 1 2 "Home". Human Phenotype Ontology. Retrieved 2018-02-28.
  6. ↑ Nizon M, Andrieux J, Rooryck C, de Blois MC, Bourel-Ponchel E, Bourgois B, et al. (January 2015). "Phenotype-genotype correlations in 17 new patients with an Xp11.23p11.22 microduplication and review of the literature". American Journal of Medical Genetics. Part A. 167A (1): 111–22. doi:10.1002/ajmg.a.36807. PMID   25425167. S2CID   32958511.
  7. ↑ Firth HV, Richards SM, Bevan AP, Clayton S, Corpas M, Rajan D, Van Vooren S, Moreau Y, Pettett RM, Carter NP (April 2009). "DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources". American Journal of Human Genetics. 84 (4): 524–33. doi:10.1016/j.ajhg.2009.03.010. PMC   2667985 . PMID   19344873.
  8. ↑ Online Mendelian Inheritance in Man (OMIM): Chromosome Xp11.22 Duplication Syndrome - 300705
  9. ↑ Grau C, Starkovich M, Azamian MS, Xia F, Cheung SW, Evans P, Henderson A, Lalani SR, Scott DA (2017-04-17). "Xp11.22 deletions encompassing CENPVL1, CENPVL2, MAGED1 and GSPT2 as a cause of syndromic X-linked intellectual disability". PLOS ONE. 12 (4): e0175962. Bibcode:2017PLoSO..1275962G. doi: 10.1371/journal.pone.0175962 . PMC   5393878 . PMID   28414775.
  10. ↑ Orivoli S, Pavlidis E, Cantalupo G, Pezzella M, Zara F, Garavelli L, Pisani F, Piccolo B (January 2016). "Xp11.22 Microduplications Including HUWE1: Case Report and Literature Review". Neuropediatrics. 47 (1): 51–6. doi:10.1055/s-0035-1566233. PMID   26587761. S2CID   38240788.
  11. 1 2 3 Moey C, Hinze SJ, Brueton L, Morton J, McMullan DJ, Kamien B, Barnett CP, Brunetti-Pierri N, Nicholl J, Gecz J, Shoubridge C (March 2016). "Xp11.2 microduplications including IQSEC2, TSPYL2 and KDM5C genes in patients with neurodevelopmental disorders". European Journal of Human Genetics. 24 (3): 373–80. doi:10.1038/ejhg.2015.123. PMC   4757771 . PMID   26059843.
  12. ↑ Zhong Q, Gao W, Du F, Wang X (July 2005). "Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis". Cell. 121 (7): 1085–95. doi: 10.1016/j.cell.2005.06.009 . PMID   15989957.
  13. 1 2 Froyen G, Corbett M, Vandewalle J, Jarvela I, Lawrence O, Meldrum C, et al. (February 2008). "Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation". American Journal of Human Genetics. 82 (2): 432–43. doi:10.1016/j.ajhg.2007.11.002. PMC   2426915 . PMID   18252223.
  14. 1 2 Froyen G, Belet S, Martinez F, Santos-Rebouças CB, Declercq M, Verbeeck J, et al. (August 2012). "Copy-number gains of HUWE1 due to replication- and recombination-based rearrangements". American Journal of Human Genetics. 91 (2): 252–64. doi:10.1016/j.ajhg.2012.06.010. PMC   3415555 . PMID   22840365.
  15. 1 2 Friez MJ, Brooks SS, Stevenson RE, Field M, Basehore MJ, Adès LC, et al. (April 2016). "HUWE1 mutations in Juberg-Marsidi and Brooks syndromes: the results of an X-chromosome exome sequencing study". BMJ Open. 6 (4): e009537. doi:10.1136/bmjopen-2015-009537. PMC   4854010 . PMID   27130160.
  16. ↑ Isrie M, Kalscheuer VM, Holvoet M, Fieremans N, Van Esch H, Devriendt K (July 2013). "HUWE1 mutation explains phenotypic severity in a case of familial idiopathic intellectual disability". European Journal of Medical Genetics. 56 (7): 379–82. doi:10.1016/j.ejmg.2013.05.005. hdl: 11858/00-001M-0000-0018-EE0C-9 . PMID   23721686.
  17. ↑ Kortschak RD, Tucker PW, Saint R (June 2000). "ARID proteins come in from the desert". Trends in Biochemical Sciences. 25 (6): 294–9. doi:10.1016/S0968-0004(00)01597-8. PMID   10838570.
  18. ↑ Iwase S, Lan F, Bayliss P, de la Torre-Ubieta L, Huarte M, Qi HH, Whetstine JR, Bonni A, Roberts TM, Shi Y (March 2007). "The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases". Cell. 128 (6): 1077–88. doi: 10.1016/j.cell.2007.02.017 . PMID   17320160.
  19. ↑ Claes S, Devriendt K, Van Goethem G, Roelen L, Meireleire J, Raeymaekers P, Cassiman JJ, Fryns JP (September 2000). "Novel syndromic form of X-linked complicated spastic paraplegia". American Journal of Medical Genetics. 94 (1): 1–4. doi:10.1002/1096-8628(20000904)94:1<1::AID-AJMG1>3.0.CO;2-V. PMID   10982473.
  20. ↑ Jensen LR, Amende M, Gurok U, Moser B, Gimmel V, Tzschach A, et al. (February 2005). "Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation". American Journal of Human Genetics. 76 (2): 227–36. doi:10.1086/427563. PMC   1196368 . PMID   15586325.
  21. ↑ Rujirabanjerd S, Nelson J, Tarpey PS, Hackett A, Edkins S, Raymond FL, Schwartz CE, Turner G, Iwase S, Shi Y, Futreal PA, Stratton MR, Gecz J (March 2010). "Identification and characterization of two novel JARID1C mutations: suggestion of an emerging genotype-phenotype correlation". European Journal of Human Genetics. 18 (3): 330–5. doi:10.1038/ejhg.2009.175. PMC   2987212 . PMID   19826449.
  22. ↑ Adegbola A, Gao H, Sommer S, Browning M (February 2008). "A novel mutation in JARID1C/SMCX in a patient with autism spectrum disorder (ASD)". American Journal of Medical Genetics. Part A. 146A (4): 505–11. doi:10.1002/ajmg.a.32142. PMID   18203167. S2CID   31730709.
  23. ↑ Iwase S, Brookes E, Agarwal S, Badeaux AI, Ito H, Vallianatos CN, Tomassy GS, Kasza T, Lin G, Thompson A, Gu L, Kwan KY, Chen C, Sartor MA, Egan B, Xu J, Shi Y (February 2016). "A Mouse Model of X-linked Intellectual Disability Associated with Impaired Removal of Histone Methylation". Cell Reports. 14 (5): 1000–1009. doi:10.1016/j.celrep.2015.12.091. PMC   4749408 . PMID   26804915.
  24. ↑ Nagase T, Ishikawa K, Suyama M, Kikuno R, Hirosawa M, Miyajima N, Tanaka A, Kotani H, Nomura N, Ohara O (February 1999). "Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro". DNA Research. 6 (1): 63–70. doi: 10.1093/dnares/6.1.63 . PMID   10231032.
  25. ↑ Kalscheuer VM, James VM, Himelright ML, Long P, Oegema R, Jensen C, Bienek M, Hu H, Haas SA, Topf M, Hoogeboom AJ, Harvey K, Walikonis R, Harvey RJ (2015). "Novel Missense Mutation A789V in IQSEC2 Underlies X-Linked Intellectual Disability in the MRX78 Family". Frontiers in Molecular Neuroscience. 8: 85. doi: 10.3389/fnmol.2015.00085 . PMC   4707274 . PMID   26793055.
  26. 1 2 Shoubridge C, Tarpey PS, Abidi F, Ramsden SL, Rujirabanjerd S, Murphy JA, et al. (June 2010). "Mutations in the guanine nucleotide exchange factor gene IQSEC2 cause nonsyndromic intellectual disability". Nature Genetics. 42 (6): 486–8. doi:10.1038/ng.588. PMC   3632837 . PMID   20473311.
  27. ↑ Tran Mau-Them F, Willems M, Albrecht B, Sanchez E, Puechberty J, Endele S, Schneider A, Ruiz Pallares N, Missirian C, Rivier F, Girard M, Holder M, Manouvrier S, Touitou I, Lefort G, Sarda P, Moncla A, Drunat S, Wieczorek D, Genevieve D (February 2014). "Expanding the phenotype of IQSEC2 mutations: truncating mutations in severe intellectual disability". European Journal of Human Genetics. 22 (2): 289–92. doi:10.1038/ejhg.2013.113. PMC   3895633 . PMID   23674175.
  28. ↑ Gandomi SK, Farwell Gonzalez KD, Parra M, Shahmirzadi L, Mancuso J, Pichurin P, Temme R, Dugan S, Zeng W, Tang S (June 2014). "Diagnostic exome sequencing identifies two novel IQSEC2 mutations associated with X-linked intellectual disability with seizures: implications for genetic counseling and clinical diagnosis". Journal of Genetic Counseling. 23 (3): 289–98. doi: 10.1007/s10897-013-9671-6 . PMID   24306141. S2CID   17850707.
  29. ↑ "TSPYL2 TSPY like 2 [Homo sapiens (human)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2018-03-01.
  30. 1 2 dos Santos RC, Barretto OC, Nonoyama K, Castro NH, Ferraz OP, Walter-Moura J, Vescio CC, Beçak W (May 1991). "X-linked syndrome: mental retardation, hip luxation, and G6PD variant [Gd(+) Butantan]". American Journal of Medical Genetics. 39 (2): 133–6. doi:10.1002/ajmg.1320390204. PMID   2063914.
  31. ↑ Stocco dos Santos RC, Castro NH, Lillia Holmes A, Beçak W, Tackels-Horne D, Lindsey CJ, Lubs HA, Stevenson RE, Schwartz CE (April 2003). "Stocco dos Santos X-linked mental retardation syndrome: clinical elucidation and localization to Xp11.3-Xq21.3". American Journal of Medical Genetics. Part A. 118A (3): 255–9. doi: 10.1002/ajmg.a.20021 . PMID   12673656. S2CID   32244491.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.